An Update on Emergent Nano-Therapeutic Strategies against Pediatric Brain Tumors

Ammu V V V Ravi Kiran1, G Kusuma Kumari1, Praveen T Krishnamurthy1

  • 1Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Rocklands, Ooty 643001, The Nilgiris, Tamil Nadu, India.

Brain Sciences
|February 23, 2024
PubMed

Insights

Pediatric brain tumors are a leading cause of childhood cancer deaths. Nanotechnology offers promising new ways to overcome treatment barriers and improve outcomes for these challenging childhood cancers.

Area of Science:

  • Oncology
  • Nanomedicine
  • Pediatric Medicine

Background:

  • Pediatric brain tumors represent a significant cause of mortality in children.
  • These tumors are highly diverse, presenting unique challenges in treatment and patient outcomes.
  • Current treatments for pediatric brain cancers face limitations including lack of specificity, poor blood-brain barrier penetration, and off-target side effects.

Purpose of the Study:

  • To review the challenges associated with treating pediatric brain cancers.
  • To explore the potential of nanotechnology in overcoming existing therapeutic barriers.
  • To highlight novel nanotechnological treatment strategies for pediatric brain tumors.

Main Methods:

  • Literature review focusing on pediatric brain tumors.
  • Analysis of current treatment limitations and side effects.
  • Examination of nanomedicine applications in oncology.

Main Results:

  • Nanoparticles show potential for improved drug delivery across the blood-brain barrier.
  • Nanotechnology enables enhanced payload capacity, stability, and safety monitoring for cancer therapies.
  • Emerging nanotechnological approaches offer new avenues for treating complex pediatric brain cancers.

Conclusions:

  • Nanotechnology presents a promising frontier for advancing the treatment of pediatric brain tumors.
  • Overcoming treatment barriers with nanomedicine could significantly improve survival rates and reduce side effects in children.
  • Further research into nanoparticle-based therapies is crucial for developing more effective treatments for pediatric brain cancers.